Tissue resident memory T cells are enriched and dysfunctional in effusion of patients with malignant tumor

被引:41
作者
Mao, Xueying [1 ]
Chen, Yue [2 ]
Lu, Xiulian [3 ]
Jin, Shuiping [1 ]
Jiang, Piao [1 ]
Deng, Zhangfeng [1 ]
Zhu, Xiaoyun [1 ]
Cai, Qichun [2 ]
Wu, Changyou [1 ]
Kang, Shuangpeng [4 ,5 ]
机构
[1] Clifford Hosp, Clin Res Ctr, Guangzhou, Peoples R China
[2] Clifford Hosp, Canc Ctr, Guangzhou, Peoples R China
[3] Obstet Clifford Hosp, Guangzhou, Peoples R China
[4] Changsha Med Univ, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, Acad Workstat, Changsha, Peoples R China
[5] Changsha Med Univ, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, Acad Workstat, 1501 Leifeng Rd, Changsha 410219, Peoples R China
关键词
Malignant effusion; Tissue resident memory T cells; PD-1; Cancer; ASCITES; PATHWAY;
D O I
10.7150/jca.83615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Most malignant effusion is secondary to metastases to the pleura or peritoneum and portend poor oncological outcomes. Malignant effusion has different tumor microenvironment from primary tumor, containing a variety of cytokines and immune cells and directly contacting with tumor cells. However, the characteristic of CD4+ T cells and CD8+ T cells in malignant effusion remains unclear.Methods Malignant effusion including peritoneal ascites and pleural fluid from thirty-five patients with malignant tumor were collected and compared with matched blood. A detailed characterization of CD4+ T cells and CD8+ T cells in malignant effusion were conducted using flow cytometry and multiple cytokines assay.Results The concentration of IL-6 in malignant effusion was significantly higher than in blood. A substantial portion of T cells in malignant effusion were CD69+ and/ or CD103+ Trm cells. Most CD4+T and CD8+T cells in malignant effusion were exhausted T cells which expressed lower levels of cytokines, cytotoxic molecules and markedly higher levels of inhibitory receptor PD-1 compared with in blood.Conclusion Our study is the first to identify the presence of Trm cells in malignant effusion and will lay the foundation for future research on anti-tumor immunity of Trm cells in malignant effusion.
引用
收藏
页码:1223 / 1231
页数:9
相关论文
共 30 条
[1]   Exit Strategies: S1P Signaling and T Cell Migration [J].
Baeyens, Audrey ;
Fang, Victoria ;
Chen, Cynthia ;
Schwab, Susan R. .
TRENDS IN IMMUNOLOGY, 2015, 36 (12) :778-787
[2]   ERS/EACTS statement on the management of malignant pleural effusions [J].
Bibby, Anna C. ;
Dorn, Patrick ;
Psallidas, Ioannis ;
Porcel, Jose M. ;
Janssen, Julius ;
Froudarakis, Marios ;
Subotic, Dragan ;
Astoul, Phillippe ;
Licht, Peter ;
Schmid, Ralph ;
Scherpereel, Arnaud ;
Rahman, Najib M. ;
Cardillo, Giuseppe ;
Maskell, Nick A. .
EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (01)
[3]   Defining 'T cell exhaustion' [J].
Blank, Christian U. ;
Haining, W. Nicholas ;
Held, Werner ;
Hogan, Patrick G. ;
Kallies, Axel ;
Lugli, Enrico ;
Lynn, Rachel C. ;
Philip, Mary ;
Rao, Anjana ;
Restifo, Nicholas P. ;
Schietinger, Andrea ;
Schumacher, Ton N. ;
Schwartzberg, Pamela L. ;
Sharpe, Arlene H. ;
Speiser, Daniel E. ;
Wherry, E. John ;
Youngblood, Benjamin A. ;
Zehn, Dietmar .
NATURE REVIEWS IMMUNOLOGY, 2019, 19 (11) :665-674
[4]   Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer [J].
Boesmueller, Hans-Christian ;
Wagner, Philipp ;
Peper, Janet Kerstin ;
Schuster, Heiko ;
Deborah Lam Pham ;
Greif, Karen ;
Beschorner, Christine ;
Rammensee, Hans-Georg ;
Stevanovie, Stefan ;
Fend, Falko ;
Staebler, Annette .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (04) :671-679
[5]   Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity [J].
Chow, Andrew ;
Schad, Sara ;
Green, Michael D. ;
Hellmann, Matthew D. ;
Allaj, Viola ;
Ceglia, Nicholas ;
Zago, Giulia ;
Shah, Nisargbhai S. ;
Sharma, Sai Kiran ;
Mattar, Marissa ;
Chan, Joseph ;
Rizvi, Hira ;
Zhong, Hong ;
Liu, Cailian ;
Bykov, Yonina ;
Zamarin, Dmitriy ;
Shi, Hongyu ;
Budhu, Sadna ;
Wohlhieter, Corrin ;
Uddin, Fathema ;
Gupta, Aditi ;
Khodos, Inna ;
Waninger, Jessica J. ;
Qin, Angel ;
Markowitz, Geoffrey J. ;
Mittal, Vivek ;
Balachandran, Vinod ;
Durham, Jennifer N. ;
Le, Dung T. ;
Zou, Weiping ;
Shah, Sohrab P. ;
McPherson, Andrew ;
Panageas, Katherine ;
Lewis, Jason S. ;
Perry, Justin S. A. ;
de Stanchina, Elisa ;
Sen, Triparna ;
Poirier, John T. ;
Wolchok, Jedd D. ;
Rudin, Charles M. ;
Merghoub, Taha .
CANCER CELL, 2021, 39 (07) :973-+
[6]   PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy [J].
Dermani, Fatemeh K. ;
Samadi, Pouria ;
Rahmani, Golebagh ;
Kohlan, Alisa K. ;
Najafi, Rezvan .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) :1313-1325
[7]   Treatment of malignant pleural effusions: the case for localized immunotherapy [J].
Donnenberg, Albert D. ;
Luketich, James D. ;
Dhupar, Rajeev ;
Donnenberg, Vera S. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[8]   CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment [J].
Edwards, Jarem ;
Wilmott, James S. ;
Madore, Jason ;
Gide, Tuba Nur ;
Quek, Camelia ;
Tasker, Annie ;
Ferguson, Angela ;
Chen, Jinbiao ;
Hewavisenti, Rehana ;
Hersey, Peter ;
Gebhardt, Thomas ;
Weninger, Wolfgang ;
Britton, Warwick J. ;
Saw, Robyn P. M. ;
Thompson, John F. ;
Menzies, Alexander M. ;
Long, Georgina V. ;
Scolyer, Richard A. ;
Palendira, Umaimainthan .
CLINICAL CANCER RESEARCH, 2018, 24 (13) :3036-3045
[9]   IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without De Novo Infiltration from Secondary Lymphoid Organs [J].
Emmerich, Jan ;
Mumm, John B. ;
Chan, Ivan H. ;
LaFace, Drake ;
Truong, Hoa ;
McClanahan, Terrill ;
Gorman, Daniel M. ;
Oft, Martin .
CANCER RESEARCH, 2012, 72 (14) :3570-3581
[10]   Malignant Pleural Effusion: Presentation, Diagnosis, and Management [J].
Gayen, Shameek .
AMERICAN JOURNAL OF MEDICINE, 2022, 135 (10) :1188-1192